Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20060063982 A1
Publication typeApplication
Application numberUS 11/165,735
Publication dateMar 23, 2006
Filing dateJun 24, 2005
Priority dateSep 14, 1999
Also published asUS6984207, US20110066004, US20120259179, US20140323884, US20160157734
Publication number11165735, 165735, US 2006/0063982 A1, US 2006/063982 A1, US 20060063982 A1, US 20060063982A1, US 2006063982 A1, US 2006063982A1, US-A1-20060063982, US-A1-2006063982, US2006/0063982A1, US2006/063982A1, US20060063982 A1, US20060063982A1, US2006063982 A1, US2006063982A1
InventorsPatrick Sullivan, Ken Cheung, Christopher Sullivan, Paul Pernambuco-Wise
Original AssigneeHoana Medical, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Passive physiological monitoring (P2M) system
US 20060063982 A1
Abstract
Passive physiological monitoring apparatus and method has a sensor for sensing physiological phenomenon. A converter converts sensed data into electrical signals and a computer receives and computes the signals and outputs computed data for real-time interactive display. The sensor is a piezoelectric film of polyvinylidene fluoride. A band-pass filter filters out noise and isolates the signals to reflect data from the body. A pre-amplifier amplifies signals. Signals detected include mechanical, thermal and acoustic signatures reflecting cardiac output, cardiac function, internal bleeding, respiratory, pulse, apnea, and temperature. A pad may incorporate the PVDF film and may be fluid-filled. The film converts mechanical energy into analog voltage signals. Analog signals are fed through the band-pass filter and the amplifier. A converter converts the analog signals to digital signals. A Fourier transform routine is used to transform into the frequency domain. A microcomputer is used for recording, analyzing and displaying data for on-line assessment and for providing realtime response. A radio-frequency filter may be connected to a cable and the film for transferring signals from the film through the cable. The sensor may be an array provided in a MEDEVAC litter or other device for measuring acoustic and hydraulic signals from the body of a patient for field monitoring, hospital monitoring, transport monitoring, home, remote monitoring.
Images(9)
Previous page
Next page
Claims(2)
1. Passive physiological monitoring apparatus comprising at least one sensor for sensing data by placing the at least one sensor on a body, a converter communicating with the at least one sensor for converting sensed data into signals, a computing device communicating with the converter for receiving and computing the voltage signals and for outputting computer data, and instrumentation communicating with the computing device for real-time interaction with the device and for display of the computed data.
2-46. (canceled)
Description
    BACKGROUND OF THE INVENTION
  • [0001]
    Minimization of the time between injury occurrence and transport to the appropriate level of medical care is necessary to ensure that wounded and sick soldiers obtain the prompt medical attention essential for their survival. During that time, aeromedical care in a MEDEVAC helicopter environment is used to identify and transport casualties.
  • [0002]
    Military units conduct aeromedical evacuations daily during times of war and peace, exposing the patient and flight/medical crew to noise or environmental stress and difficult monitoring conditions. As in the civilian community, military nurses depend on reliable and efficient monitoring devices to provide accurate patient care in various environments, some of which are hostile and obtrusive to the use of conventional monitoring instrumentation. While aeromedical evacuation is a life-saving process for many, it is nearly impossible for medical personnel to monitor vital signs in a high noise environment.
  • [0003]
    Vital signs monitoring is normally a simple and routine procedure involving collection of pulse, respiration and blood pressure data. In a relatively quiet environment, these parameters are easily detected. However, acquisition of physiological signals of interest in a helicopter environment is a challenging problem for several reasons. Limitations on vital signs collection include high noise, vibration, auditory distractions, ineffective monitoring equipment, cramped working conditions, bulky gear during air evacuation, and electromagnetic interference with aircraft systems caused by some medical equipment. The additional complexity of leads and electrodes compounds the noise and environmental problems. The physiological parameters of vital signs fall within the helicopter-generated frequencies. Helicopter frequencies have a much greater power in those frequencies as well. Vibrational and acoustic artifacts are also major problems. The signal to noise problem must therefore be solved by other means in addition to low and high band pass filtering approaches. Due to the limiting work conditions, medical personnel cannot use a stethoscope to accurately monitor heart activity or blood pressure.
  • [0004]
    The military medical system needs a portable, non-invasive device capable of monitoring a soldier's vital signs in the field environment under less than ideal circumstances. This system needs to be useful to military medical personnel across the spectrum of care delivery, such as in-mass casualty situations, aeromedical evacuations, ground ambulance transports, hospital wards, and intensive care units. A recent study found that thirty-two percent of aircraft medical devices flown onboard a rotor-wing MEDEVAC aircraft failed at least one environmental test.
  • [0005]
    Quartz crystals are minerals that create an electric field known as piezoelectricity when pressure is applied. Materials scientists have found other materials with piezoelectric properties. The versatility and potential uses for piezoelectric materials have been known but cost-prohibitive for some time.
  • [0006]
    However, recent decreases in the cost of manufacturing now permit greater application by engineers and researchers. The advantageous qualities of piezoelectric materials have been applied to medicine, security, acoustics, defense, geology and other fields. Development of applications with piezoelectric materials is in its infancy.
  • [0007]
    The medical practice and research application of piezoelectric-based instrumentation is gaining momentum. Piezoelectric methods have been successfully used in plethysmography, blood pressure monitoring by piezoelectric contact microphone, heart rate monitoring in avian embryos and hatchlings and piezoelectric probes. Piezoelectric materials are used as detectors of sensitive motion to measure human tremor, small body movements of animals in response to pharmacological manipulation, and respiratory motion for nuclear magnetic resonance (NMR) animal experiments. In combination with ultrasound, piezoelectric methods have been used to assess coronary hemodynamics, elastic tensor, intra-arterial imaging, and receptor field dimensions. In addition, piezoelectric transducers have been attached to the chest wall and used with automated auscultation devices and microcomputers for lung sound analysis. Piezoelectric film has been applied and studied to determine joint contact stress, and piezoelectric disks have been used for recording muscle sounds and qualitative monitoring of the neuromuscular block.
  • [0008]
    Stochastic wave theory, as commonly used in ocean engineering to analyze pseudo-periodic phenomena, indicates spectral peaks from respiration and heart rate. Human heartbeats, respiration, and blood pressure are repetitive in nature, reflecting complex mechano-acoustical events. However, various problems with piezoelectric instrumentation development prevent its full realization. Measurement of human tremor only works well when the environment is absolutely silent. In fact, extraneous noise such as equipment, fans, people talking, and the patient's own voice routinely exists in most hospital rooms. That noise masks and distorts the signal of interest, thus limiting the practicality of piezoelectric instrumentation. Animal noises make data collection difficult in laboratory animal studies. In non-laboratory environments, medical uses of piezoelectric instrumentation for humans remains a problem because of the inherent signal-noise problem.
  • [0009]
    A primary mission of military nurses is to ensure that wounded and sick soldiers obtain prompt medical attention and/or evacuation to definitive medical care. The actions performed during the time period between a battlefield injury and the transfer of casualties to appropriate medical treatment is critical for the welfare of the soldier, and can be the difference between life and death. It is during this critical time period where diagnosis and treatment begins and also when evacuation—for example via MEDEVAC helicopter—occurs.
  • [0010]
    Unfortunately, the extremely high noise and vibration inherent in the helicopter environment prevents nursing and medical personnel from accurately measuring vital signs. Not only are electronic medical monitors rendered ineffective with the high vibrations; traditional methods of measuring pulse and blood pressure using a stethoscope become unreliable in the high noise. Cramped working conditions and bulky gear during air evacuation exacerbate these problems.
  • [0011]
    Most conventional methods use devices that employ electrodes, leads, wires, and cuffs to measure one or more vital signs, for example, blood pressure machine, ECG monitor, pulse oximeter. Existing monitors require some sort of attachment and thus are not passive. In addition, conventional equipment is highly sensitive to noise, such as a helicopter or airplane engines and rotors.
  • [0012]
    Clearly, what is needed for this common situation is a monitor that can consistently and accurately measure vital signs during a medical evacuation where there is high noise and vibration. The monitor being relatively autonomous intervention by a nurse or technician is not required. With the added capability of telemetry for remote monitoring and communication, information may be forwarded in real-time via wireless communication to the destination where medical personnel and other caregivers are located.
  • [0013]
    Needs exist to develop better methods and apparatus for physiological monitoring.
  • SUMMARY OF THE INVENTION
  • [0014]
    The present invention is known as Passive Physiological Monitoring, P2M, or simply P2M. Data records with vast information, such as blood pressure, are measured, recorded, and may later be delineated to determine the physical condition of the subject being monitored.
  • [0015]
    Recent developments in materials science and data processing have created the potential for a new monitoring device using piezoelectric film, an electrically active fluoropolymer. Although the medical applications of piezoelectric film are still at the infant stage, the testing of medical instruments is promising.
  • [0016]
    The cardiovascular system is modeled as a system of pipes, pumps, and other appendices, with the engineering phenomenon known as “water hammer” as the basis for a working model for data analysis in the calculation of blood pressure.
  • [0017]
    “Water hammer” is a compression wave transmitted through the household plumbing network of pipes and valves when household water is abruptly shut off. The result is a noticeable sound and the deterioration of the plumbing system. Water hammer is caused by the increase in pipe pressure caused by sudden velocity change, typically after water is shut off during a valve closing. The compression wave is described as follows: c = 1 ρ * P V ( 1 )
  • [0018]
    where
  • [0019]
    c=speed of the compression wave (ft/sec);
  • [0020]
    dV=change in velocity (Vinitial−Vfinal);
  • [0021]
    ρ=density of the fluid; and
  • [0022]
    dP=change in pressure.
  • [0023]
    Skalak (1966) applied the linearized theory of viscous flow to develop a basis for understanding the main waveform features in arteries and veins. The vascular system is equivalent to a network of non-uniform transmission lines.
  • [0024]
    Womersly (1957) had applied those principles to a single uniform tube representing an arterial segment and compared the results to the experimental data taken in a dog, prior to Skalak's theory. Good agreement was reported between the measured flow and the flow computed from the measured pressure gradient.
  • [0025]
    Anliker (1968) showed that the dispersion phenomena associated with waves propagating in blood vessels are potential measures of the distubility of the vessels and other cardiac parameters. Anliker assumed that vessels behave like thin-walled cylindrical shells filled with inviscid compressible fluid. More complete models have provided good agreement.
  • [0026]
    Karr (1982) studied pressure wave velocity on human subjects and developed a method to determine the pulse propagation speed. The invention recognizes that such information may be used to determine plaque buildup, cholesterol concentration on the arterial wall, and arterial wall thickness.
  • [0027]
    Equation (1) allows for determination of pressure change (dP) from the heart pulsing based on the dispersion relationship between pulse wave velocity (c) and flow velocity (v). Karr's method measures flow velocity to determine dP, which is related to systolic pressure (pS) and diastolic pressure (pD).
  • [0028]
    The new invention measures the pressure energy from heartbeat and respiration collectively. The heart contribution to the energy spectrum is determined by removing the respiration contribution to the energy spectrum. Respiration energy is filtered out by comparing the energy spectrum calculations of velocity with velocity measures using electromagnetic and doppler methods. Since the sympathetic tone may influence blood pressure measurement accuracy, the new monitor can be configured for one of its piezoelectric sensors to serve as a dedicated doppler sensor that uses ultrasonics to adjust interpretations of data as a function of the sympathetic tone of the patient. The selective omission of P2M signals and the selective comparison of P2M sensor data with data from other parts of the body, as well as comparisons between two or more simultaneously triggered sensors, isolates energy contributions from the heart. P2M energy spectra determined from the foot differs from spectra derived from the chest area, which provides a means for isolating heart energy as the foot spectra is largely void of energy from respiration.
  • [0029]
    Once velocity (v) is known, the relation between systolic and diastolic blood pressure (2) and the Bernoulli equation (3) is used to measure blood pressure. The Bernoulli equation is a fundamental relationship in fluid mechanics that is derived from Newtonian mechanics and the principle of conservation of energy. A more compressive version of the same equation can be developed to reflect more complicated non-steady flows. p = pD + 1 3 * ( pS + pD ) ( 2 )
  • [0030]
    where
  • [0031]
    pS=systolic pressure;
  • [0032]
    pD=diastolic pressure; and
  • [0033]
    p=average pressure.
    p=ρgh+*ρ*V 2   (3)
  • [0034]
    where
  • [0035]
    ρ=fluid density,
  • [0036]
    g=gravitational constant, and
  • [0037]
    h=height, head energy term.
  • [0038]
    From these equations we can develop expressions for pD and pS, both as a function of the pulse wave velocity (c), flow velocity (v) and pulse wave pressure (dP):
    pD=*ρ*v 2 −ρ*C*dV   (4)
    pS=pD+ρ*C*dv   (5)
  • [0039]
    P2M is well-suited to assist medical personnel in several areas including, but not limited to, the following situations:
  • [0040]
    (1) Medical monitoring of vital signs of severely injured persons in high noise and vibration environments such as rescue helicopter where current monitoring techniques are cumbersome or impossible;
  • [0041]
    (2) Monitoring casualties resulting from major disasters such as aircraft accidents, earthquakes and floods;
  • [0042]
    (3) Physiological monitoring of large numbers of patients through a “smart stretcher” easily deployed for field use by medical personnel;
  • [0043]
    (4) Continuous military hospital bed monitoring without disturbing patients; and
  • [0044]
    (5) Patient monitoring when treatment is delayed due to temporary overload of medical facilities.
  • [0045]
    The development of the P2M or a passive sensor array (multi-sensor system) is a significant innovation in passive monitoring. Through the use of a grid of passive sensors, noise can be reduced through correlating signals from different pads to discern noise from biological signals. This is very important in high-noise environments. Additionally, the significance of a passive multi-sensor system is that it affords the opportunity to more comprehensively monitor a patient. As a tool, the grid of passive sensors provides an innovative way to monitor patients in adverse ambient conditions. The system provides a tool whereby parameters other than blood pressure, heart rate, and respiration can be measured. These parameters include, but are not limited to, patient movement and sleep habits, pulse strength over various portions of the body, relative blood flow volumes, and cardiac output, among others.
  • [0046]
    The main components of the Passive Physiological (P2M) system are the passive sensor, hardware for amplification, filtering, data-acquisition, and signal-analysis software. In a preferred embodiment, the single passive sensor has dimensions 8″10″ and is preferably encased in a protective covering. Leads from the sensor attach to the electronics (amplifier, filter, data-acquisition card, desktop computer) where the raw analog voltage signal is filtered and amplified and converted to digital form. Digital filtering and software manipulation of the data in the form of frequency analyses are then performed. Finally, signal processing techniques are then used to extract physiological information from the digital signal.
  • [0047]
    The sensor pad is preferably placed directly beneath the back of a patient lying supine on a MEDEVAC litter. The mechanical/acoustic signals created by cardio-pulmonary function are transmitted through the body onto the passive sensor, which converts the signal into an analog voltage. An illustration of the existing P2M setup is shown in FIG. 6. Among the major hardware used for the laboratory setup are: desktop computer, a multi-function programmable charge amplifier and roll-around rack to encase all of the hardware. To maintain versatility for initial research and development, most of the equipment were chosen for functionality at the expense of space efficiency.
  • [0048]
    It is an object of the present invention to provide the military medical community with an inexpensive, non-restrictive, portable, light-weight, accurate, and reliable device that can be used in field or fixed facilities to provide an accurate measurement of heart rate, respiration and blood pressure in high noise and vibration environments and thus improve medical care in mass casualty situations, aeromedical evacuations and hospital settings.
  • [0049]
    It is an object of the present invention to adjust the signal noise to enable the use of piezoelectric instruments in aeromedical transport of patients, hospital bed monitoring, and other applications in the military and civilian medical environment.
  • [0050]
    It is an object of the present invention to develop a prototype physiological monitor using piezoelectric film in various field environments. The variables of accuracy, precision, user characteristics, and patient comfort determine the value of a field instrument for collection data on vital signs.
  • [0051]
    It is an object of the present invention to provide a non-invasive means for monitoring vital functions without the use of electrical leads or wiring on the patient. The use of the human body's acoustic and electromagnetic signals to determine heart rate, respirations, and blood pressure.
  • [0052]
    These and further and other objects and features of the invention are apparent in the disclosure, which includes the above and ongoing written specification, with the claims and the drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0053]
    FIG. 1 is a schematic of the P2M system components.
  • [0054]
    FIG. 2 is a perspective view of the P2M system.
  • [0055]
    FIG. 3 is a graphical comparison of the P2M bench test results and the human evaluator measurements.
  • [0056]
    FIG. 4 is a front view of the front panel display and user interface of the P2M system in Acquire Mode.
  • [0057]
    FIG. 5 is a front view of the front panel display of the P2M system in Monitor Mode.
  • [0058]
    FIG. 6 is a schematic view of a preferred embodiment of the P2M sensor.
  • [0059]
    FIG. 7 shows one of the graphical user interfaces (GUI) of the P2M system.
  • [0060]
    FIG. 8 shows the graphical user interface of the P2M system showing time-series and frequency-domain representations of physiological data.
  • [0061]
    FIG. 9 shows measurement of Pulse-Wave Travel Time (PWTT) FIG. 10 shows a system test and evaluation results in a graph.
  • [0062]
    FIG. 11 high noise and vibration testing of the P2M at Wheeler Army Air Field.
  • [0063]
    FIG. 12 shows the measurement through a body armor.
  • [0064]
    FIG. 13 shows testing through body armor and MOPP gear combined.
  • [0065]
    FIG. 14 shows a schematic view of the Passive Physiological Monitoring (P2M) System Using a passive sensor array and microelectronics incorporated into a MEDEVAC litter.
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • [0066]
    The preferred P2M system is a monitoring device with two major subsystems, one to measure signals and the other to process data into meaningful information.
  • [0067]
    FIG. 1 shows a schematic of the system, and FIG. 2 shows a perspective view of the system. First, the piezoelectric film, an electrically active fluoropolymer converts mechanical energy such as movement caused by a heartbeat into voltage measurements capable of supporting time series analysis techniques. Second, the voltage is recorded by and analyzed using a microcomputer controlled system, the purpose of which is to discriminate the signal from background noise and display it on a screen or printout. Techniques such as preamplifying and preconditioning through the use of high and low-band pass filters reduces noise.
  • [0068]
    The piezoelectric material 1 used is the polymer polyvinylidene fluoride (PVDF), which can be shaped into cables, thin film, or thick tiles. PVDF piezoelectric film is environmentally rugged, lightweight, flexible, inherently reliable, sturdy, easily repairable and transportable with excessive assembly or disassembly. Since the material is inert, it may be used inside the human body. Ultraviolet radiation passes harmlessly through the PVDF film, which may be produced in varying thicknesses. In addition, the piezoelectric film is waterproof, operates between 0 and 145 degrees Centigrade, and does not tear under stress. PVDF may convert a temperature reading into an electric output. The PVDF film is incorporated into a fluid-filled vinyl pad, approximately 10 cm by 10 cm in surface area. This is placed on/under/above various locations of the patient.
  • [0069]
    P2M detects cardiac and respiratory motion, and monitors pulse, respiration and apnea episodes 3. Cardiac and respiratory movements are simultaneously recorded by selective filtering of original signal. The piezoelectric element 1 is a pressure—sensing detector acting as a highly sensitive strain gage providing high dynamic range and linearity. Analog signals are fed through a band-pass filter into an amplifier (200-5000) 5 and are visually displayed. Analog acoustic signals are converted to digital values using a multi-channel converter 7 at a sampling rate of up to 5 kHz. Data is transformed to the frequency domain using Fast Fourier Transform (FFT). The system uses a microcomputer 9 for recording, analysis and presentation of data, which allows for on-line assessment of data and realtime decisions.
  • [0070]
    In its simplest mode of operation PVDF piezoelectric film 1 acts as a piezoelectric strain gage. The voltage output is up to four orders of magnitude higher than that produced by a nonamplified signal from circuitry used with resistive wire. Linearity and frequency response are excellent. Although similarities to a strain gage exist, current need not be applied since the device is electrically self-generating. Unlike the strain gage, the present invention does not produce an electric charge ad infinitum with sustained stress. The slowest frequency the polymer film detects is a thousand seconds for an electrical event to occur, and the highest is one gigahertz (microwave). The piezoelectric film is passive and biologically non-hazardous, as opposed to traditional strain gages that require an applied current.
  • [0071]
    PVDF sheets are commercial off-the-shelf (COTS) products, the type and specifications of which were chosen based on optimum sensitivity range and resilience. Each sheet contains seven-foot attached shielded twisted-pair (for noise rejection) leads 11 to transmit the charge produced by the sheets.
  • [0072]
    The piezoelectric sheets 1 are placed under a patient's chest and foot or at similarly remote areas of the body, or may be put on like a wrapped cuff. The change in pressure exerted by the patient's respiration and heartbeat causes the piezoelectric film to generate voltages, which is carried via nonmagnetic miniature coaxial cable 11 through a radio frequency filter 13. The signal is then directed to a high input-impedance amplifier 5 and computer system 7 for data processing. A conventional oscilloscope and a chart recorder displays the output. Respiration and heart rate 15 are then calculated by the energy spectrum from the time series data.
  • [0073]
    Several techniques reduce noise and vibration interferences. Active cancellation uses two piezoelectric sensors, one of which is not in contact with the body. The sensor not attached to the body is exposed to environmentally acoustic and vibrational signals, while the sensor attached to the body is exposed to environmental as well as body signals. Subtraction of one output from the other output yields the body signal of interest.
  • [0074]
    Another preferred technique to reduce noise involves band-pass filtering/band-stop filtering. By identifying the extraneous electronic or acoustic noise and its particular frequencies, band-pass or band-stop filtering eliminates extraneous signals from the overall signal.
  • [0075]
    Additionally, signal processing techniques that use a prior knowledge of the expected signals extract the desired information from the piezoelectric signal. Spectral techniques help to identify the frequencies and amplitudes of the events of interest and discern them from extraneous noise.
  • [0076]
    Cardiac action analysis uses a bandpass frequency limit of 0.1-4.0 Hz, and respiration analysis uses a frequency limit from 0.01-3.0 Hz. The filtered cardiac and respiration signals are fed to a recording system. Body movements are analyzed by bandpass filtering the original signal with frequency limits from 0.1-20 Hz.
  • [0077]
    Once the signal produced by the film sensor is converted to voltages, amplified and filtered, it is processed through the P2M instrumentation. The hardware equipment includes, but is not limited to, a 586 processor computer 9 with enhanced RAM and disk capacity to handle large amounts of data. A board with a range that includes acoustic frequencies facilitates data acquisition, signal conditioning and signal processing.
  • [0078]
    For system operation, a master program 17 combines the three separate software modules of data acquisition/control, signal processing/analysis, and data display/user interface. The LabVIEW™ “G” graphical programming language was used for all three subroutine programs. The analog voltage signal is digitized and analyzed in time and frequency domains. Routines developed for signal conditioning and analysis include digital filtering, spectral analysis, auto correlation, and noise—rejection programs. The data is displayed real-time in either Monitor or Acquisition mode. Monitor mode displays the current data and discards old readings as new updates are processed, while Acquisition mode saves data for future analysis. The voluminous data must not exceed the disk-storage capacity of the computer in Acquisition mode.
  • [0079]
    For protection and ease of transport, the entire P2M system 19 is encased in a metal technical enclosure 21 with casters (not shown) and locking glass door (not shown), as shown in FIG. 2. The equipment also includes a MEDEVAC stretcher 23 on which the sensor is mounted. This device may be incorporated into a litter to eliminate the need for patient attachment or miniaturized as a portable field device in a purse with a wireless communication setup.
  • [0080]
    Significant field and analysis testing was conducted to confirm the workability and accuracy of the P2M system. The piezoelectric film measures mechanical, thermal and acoustic signals. That high sensitivity is necessary to measure vital signals non-intrusively. For pulse rate, the physical beating of the heart is transmitted through the body into the piezo-film sensor pad as mechanical impulses. The respiration is measured by the mechanical impulse transmitted to the sensor based on chest movements. The sensitive piezo-film sensor pad measures all extraneous movement and speech, resulting in a voltage signal output that is superimposed upon the physiological signals. As a result, movement or speech by the subject may cause a reading error.
  • [0081]
    The P2M sensor measures all physical impulses in the measuring environment, including the patient's physiological signals, nearby human noise and activity signals, noise and vibration from the machinery, and electromagnetic (EM) noise emitted from the lights and instrumentation. While the output signal includes all of these signals, many are too weak to affect the measurement while others such as EM noise corrupt the reading. Running the signal through filters and other signal—processing algorithms removes the noise. The conditioned signal is then analyzed through routines, including a fast Fourier transform (FFT) which identifies the primary signal frequencies. For a still, speechless patient, the primary frequency is usually respiration, and the second highest frequency is heart rate. Patient positioning and frequency harmonics may complicate the distinction, requiring additional logic to separate and identify the heart and respiration frequency peaks. The logic algorithms must be robust enough to define the respiration and heart peaks for a variety of conditions.
  • [0082]
    To increase resolution, a large number of high sampling rate data points were selected and re-sampled at a lower rate to simplify computation for accurate analysis. The minimum sampling interval was thirty seconds.
  • [0083]
    FIG. 3 shows the results for the twenty respiration/pulse-rate measurements performed with the P2M system. Human evaluator measurements were performed simultaneously as a control. P2M accurately measured pulse 25 and respiration 27 under ideal conditions, but patient movement or speech interfered with accurate measurement. Heart rate measurement quality was not reduced by the absence of respiration, and P2M matched the control measurement results 29, 31 with an error of less than beat per minute.
  • [0084]
    FIG. 4 shows the P2M front panel in Acquisition mode. The upper graph 33 displays a thirty-second window of time-series measurements of all physiological signals. Heartbeat spikes are shown in the upper (time series) graph 33, along with a lower-frequency sinusoidal function which corresponds to the respiration signal. The lower graph 35 shows the same data in the frequency domain. The first and largest spike 37 corresponds to approximately 16.4 respirations per minute. The control group 31 measured 172 respirations per minute. The large amplitude of the spike indicates that respiration is the largest impulse measured by the sensor pad. The second-largest spike 39 is sixty times per minute, which was identical to the actual heart rate measured by a fingertip-clip heart-rate monitor. The power as measured by the amplitude is less than one-third of that found in the respiration frequency, but the ratio varies based on the physiology and sensor pad positioning of the patient. The smaller spikes 41 in the lower graph represent respiration and heart-rate harmonics, a result of the harmonics not being a perfect sinusoidal function. Since the heart rate might fall at exactly the same frequency as a respiration harmonic, it is necessary for logic algorithms to check for harmonics. The heart rate and respiration harmonics may be differentiated by comparing signals taken from different parts of the body.
  • [0085]
    The buttons and menus 43 on the front panel of the interface program enables the control of data acquisition and analysis routines. The thirty-second data records may be saved to file for archiving or additional evaluation.
  • [0086]
    FIG. 5 shows the P2M system in Monitor mode. The top graph 45 shows the time-series data, with the characteristic higher-frequency heartbeat spikes 47 superimposed over a lower—frequency respiration wave 49. The middle graph 51 shows heart rate 53 and respiration 55 as updated every five seconds. As a new five-second data string is acquired, the oldest five seconds of data is discarded, and the heart rate and respiration are re-calculated by analyzing the thirty-second data string with the new data. The upper curve 53 is colored red to signify heart rate, while the lower curve 55 is colored blue to signify respiration. Heart rate appears steady in the mid-50s range, with respiration in the mid-teens. Both compare favorably (2) with human control measurements. The anomaly 57 after 25 updates is attributable to patient movement or an extraneous and errant noise/vibration event. The bottom graph 59 shows an FFT of the time-series signal.
  • [0087]
    Regular voltage signals of heart beat provide strength signals as voltage levels that are related to blood pressure. Times between signals at varied parts of the body or patterns of secondary signals provide information on circulation or blockage or interference with blood flow.
  • [0088]
    In another preferred embodiment, FIG. 6 shows a schematic view of the P2M system with a single passive sensor 61 positioned on a patient 63. FIG. 7 shows one of the graphical user interfaces (GUI) of the P2M system. The upper chart 65 shows a 30-second window of digital voltage data, where the low-frequency oscillations are caused by respiration and the higher-frequency spikes are the result of heartbeat measurements of the patient on the litter. The time-series signal is converted to frequency data via a Fourier transform and displayed as a power spectrum, shown in the middle chart 67. From this data, pulse and respiration can be extracted by examining the power associated with the dominant frequencies 69.
  • [0089]
    In a preferred method of blood pressure measurement passive measurement of blood pressure (systolic and diastolic) may be conducted using pulse wave analyses. Measurement and characterization of the pulse-wave velocity (PWV), or alternately, the pulse-wave travel time (PWTT), inherently requires more than one measurement location. Thus, plural sensors are required for measurements in different locations. The sensors may measure pulse-wave characteristics, for example, along the brachial artery, along with other measurements described herein.
  • [0090]
    FIG. 8 shows measurement results of the pulse at two locations along the arm. The temporal separation between the two corresponding peaks 71, 73 gives the Pulse-Wave Travel Time (PWTT). This value can be used to correlate systolic and diastolic blood pressure. As such, the calibration must be performed simultaneously for several measurements of PWTT and blood pressure to construct a calibration curve. Barschdorff & Erig showed that the relationship between blood pressures (systolic and diastolic) are approximately linear with PWV and PWTT.
  • [0091]
    Testing and evaluation of the P2M system was performed at TAMC in February, 1998. Simultaneous measurements of pulse and respiration were performed with the P2M, an electronic monitor, and by human evaluation. FIG. 9 shows a photograph of the testing performed at TAMC. A total of 11 volunteers were monitored following the project's testing protocol.
  • [0092]
    FIG. 10 displays the results of the testing. The P2M was over 95% accurate as compared to conventional methods, and the several instances where the P2M was not in agreement with conventional methods proved to be very valuable in subsequent modifications and improvements to the system software. In addition, 12 volunteer nurses performed physiological monitoring of pulse and respiration using the P2M, electronic monitor, and human evaluation. Following the monitoring, the nurses completed a survey comparing and ranking the usage of the three methods.
  • [0093]
    Testing of the P2M system for pulse and respiration in a high noise and vibration environment was performed at Wheeler Army Air Field, on Mar. 5, 1999. Tests were-performed during static display of a MEDEVAC helicopter. The main purpose of the test was to characterize the high noise/vibration environment using the P2M, microphones and accelerometers. Results showed that through filtering and signal analyses, the P2M was able to discern physiological signals from the high amplitude and frequency noise caused by the helicopter to output accurately pulse and respiration. No conventional methods were performed at this test due to the high-noise environment, which would render those methods useless.
  • [0094]
    FIG. 11 shows the high noise and vibration testing of P2M at Wheeler Army Air Field, on Mar. 5, 1999.
  • [0095]
    Next, in response to inquiries made by the flight medics during the Mar. 5, 1999 testing at Wheeler, the ability of P2M system to accurately monitor pulse and respiration through layers of clothing and gear was tested. Fragmentation protective body armor, Military Oriented Protective Posture (MOPP) gear, and a combination of the two were tested using the P2M system. Results showed that the P2M performed with higher fidelity with the additional layers between the subject and the sensor, which is largely due to the increased contact area and efficient transmission of mechanical and acoustic signals through the solid layers.
  • [0096]
    The single-sensor P2M configuration that has been demonstrated to accurately measure pulse and respiration is very sensitive to the patient position relative to the main sensor pad. The quality and magnitude of the physiological signals received by the system depends on this positioning. The preferred optimum placement is to situate the sensor directly beneath the center of the patient's chest. If the sensor is moved from this placement, or if the patient position changes, the integrity of the incoming signal also changes. Thus, a preferred configuration uses multiple sensors in a pattern that covers the entire region of the litter on which the patient would lie so that regardless of patient movement and position, there will always be one or more active sensors in optimum measurement placements.
  • [0097]
    In a preferred embodiment, the invention is a passive system using an array of distributed sensors (or “multi-sensor”) capable of accurately and robustly monitoring certain physiological signals of the human body. These signals, in turn, may be processed for determination of vital signs that are currently used by nurses and other caregivers, for example, heart rate, respiration, and systolic/diastolic blood pressure.
  • [0098]
    Passive monitoring of such parameters as cardiac output, cardiac function, and internal bleeding are within the scope of this invention. The invention uniquely provides a device that is passive (completely non-invasive), unobtrusive, and autonomous; i.e., the apparatus in no way interferes either with the patient's mobility or with other monitoring equipment, and is capable of functioning with a minimum of technical expertise. In addition, the equipment functions reliably in high-noise environments and other situations that render alternative and existing methods ineffective. These environments include, but are not limited to, medical evacuation (MEDEVAC) by helicopter or ambulance, and operation through Military Oriented Protective Posture (MOPP) gear and body armor.
  • [0099]
    With the development of a reliable multi-sensor monitoring system for such rugged and noisy operation, the application to the hospital ICU environment, where noise is substantially lower, is considerably more straightforward. Completely non-invasive, passive, pulse, respiration, blood pressure (and detection of cardiac output, internal bleeding, shock, etc.) measurements using a sensor system that is undetectable to the patient have considerable intrinsic value even in noise-free surroundings. The passive and autonomous operation of such a system is suitable for telemetry and real-time remote monitoring, and the final feature of the invention is a telemetry design feature for distance and remote monitoring.
  • [0100]
    FIG. 14 shows a schematic of the P2M using a passive sensor array and microelectronics incorporated into a MEDEVAC litter. A schematic of the inventive technology, incorporated into a MEDEVAC litter, is shown in FIG. 14 below. The litter 75 is covered in an array 77 of 32 sensors, each of which can measure acoustic and hydraulic inputs from the patient 63. Each of these signals contains a measure of physiologically generated signal and environmental noise. The environmental noise on each pad will be similar, whereas the physiologically generated signals may be position dependent. This information is used to separate the signal from the noise using proven techniques. Position dependent physiological signals are used to determine patient position, heart rate, respiration, blood pressure, pulse strength distribution, and potentially some measure of cardiac output.
  • [0101]
    The invention may be incorporated into a wide range of applications apart from the MEDEVAC litter. The passive sensor array may be configured without much change to operate on a hospital bed or an ordinary mattress used at home. Of particular note is the area of premature infant care. In this case, the attachment of sensor leads to the infant may often be difficult, causing irritation of sensitive skin and entanglement in leads. The sensor may be incorporated into equipment for use in both civilian and military sectors. The sensor may be incorporated into field equipment, clothes and uniforms. This includes, but is not limited to, cervical collars, body armor, biological and/or chemical hazard protection suits, extraction devices, clothes, cushions on seats and seatbacks. Exercise equipment, such as stationary bicycles, treadmills or steppers may benefit by incorporating sensors into the supports.
  • [0102]
    Physiological indicators such as heart rate may be detected through handholds as an aid to regulating the exercise regime. Other useful applications might include the use of a passive sensor system in a chair or couch used for psychological examinations. Scrutiny of the subject's physiological signs may give indications of emotional disturbance caused by trigger words or events during counseling. The size of each sensor, number of sensors in the array, and configuration of the sensor array may be tailored, without much experimentation, to particular needs and situations. For a mattress, for example, 32 or more sensors in a rectangular array may be required.
  • [0103]
    The preferred passive sensor may use piezo-electric films and ceramics, hydrophones, microphones or pressure transducers. Amplification hardware may include signal amplification circuitry and hardware, e.g., charge amplifier. Data acquisition hardware and signal processing hardware (circuitry) and software are used in the system. For the interface between sensor and patient either solid, fluidized (air) or fluid layer may be used, as for example, gel, water, foam, rubber, plastic, etc. The interface facilitates transmittal of physiological signals.
  • [0104]
    The invention has great medical value for field monitoring, hospital monitoring, transport monitoring, and home/remote monitoring. For example, the invention may have application in every hospital for passive monitoring of patients. The invention being undetectable to the patient, which adds comfort to the monitoring process.
  • [0105]
    While the invention has been described with reference to specific embodiments, modifications and variations of the invention may be constructed without departing from the scope of the invention.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3742937 *Jan 20, 1971Jul 3, 1973Manuel BCardiac monitor
US3898981 *Aug 17, 1973Aug 12, 1975Electronic Monitors IncRespiration monitoring apparatus
US4033332 *Jul 21, 1975Jul 5, 1977Cavitron CorporationActivity and respiration monitor
US4245648 *Sep 20, 1978Jan 20, 1981Trimmer Gordon AMethod and apparatus for measuring blood pressure and pulse rate
US4320766 *Mar 10, 1980Mar 23, 1982Instrumentarium OyApparatus in medicine for the monitoring and or recording of the body movements of a person on a bed, for instance of a patient
US4359726 *Jan 27, 1981Nov 16, 1982Jacques LewinerComposite sheets constituting electromechanical transducers and transducers equipped with such sheets
US4381788 *Feb 27, 1981May 3, 1983Douglas David WMethod and apparatus for detecting apnea
US4403215 *Apr 17, 1981Sep 6, 1983Hellige, GmbhApparatus for automatically monitoring body functions
US4428380 *Sep 11, 1980Jan 31, 1984Hughes Aircraft CompanyMethod and improved apparatus for analyzing activity
US4429699 *Feb 12, 1981Feb 7, 1984Asulab AgBlood pressure measuring equipment
US4438771 *Apr 26, 1982Mar 27, 1984University Of Virginia Alumni Patents FoundationPassive contactless monitor for detecting cessation of cardiopulmonary
US4446869 *Mar 7, 1983May 8, 1984Trimed, Inc.Water absorbing trap to protect an infrared exhaled carbon dioxide apnea monitor of a patient's respiration
US4459991 *Feb 12, 1981Jul 17, 1984Asulab A.G.Blood pressure measuring equipment
US4474185 *May 12, 1982Oct 2, 1984Diamond Donald ABody movement detector
US4475557 *Apr 23, 1982Oct 9, 1984Asulab S.A.Method and apparatus for performing blood pressure measurements
US4494553 *Apr 1, 1981Jan 22, 1985F. William CarrVital signs monitor
US4509527 *Apr 8, 1983Apr 9, 1985Timex Medical Products CorporationCardio-respiration transducer
US4513748 *Aug 30, 1983Apr 30, 1985Rca CorporationDual frequency heart rate monitor utilizing doppler radar
US4537200 *Jul 7, 1983Aug 27, 1985The Board Of Trustees Of The Leland Stanford Junior UniversityECG enhancement by adaptive cancellation of electrosurgical interference
US4562723 *Jul 27, 1984Jan 7, 1986Hubner Hans JMethod of and apparatus for the measurement of subterranean atmospheric parameters
US4595016 *Jan 30, 1985Jun 17, 1986Mine Safety Appliances Co.APNEA monitor
US4657026 *Jul 14, 1986Apr 14, 1987Tagg James RApnea alarm systems
US4660564 *Apr 1, 1985Apr 28, 1987Teltec Electronic Equipment AbApparatus for measuring pulsetile part-structures within a living body
US4686999 *Apr 10, 1985Aug 18, 1987Tri Fund Research CorporationMulti-channel ventilation monitor and method
US4734044 *Apr 18, 1986Mar 29, 1988Radice Peter FConnectors for use with piezoelectric polymeric film transducers
US4757825 *Oct 31, 1985Jul 19, 1988Diamond Research Group, Inc.Cardio-pulmonary activity monitor
US4773422 *Apr 30, 1987Sep 27, 1988Nonin Medical, Inc.Single channel pulse oximeter
US4827763 *Apr 11, 1986May 9, 1989Purdue Research FoundationPressure mapping system with capacitive measuring pad
US4862144 *Apr 4, 1988Aug 29, 1989Tao Billy S KMovement monitor
US4926866 *Oct 24, 1988May 22, 1990Lee Arnold St JSystem for gathering physiological data
US4967760 *Feb 2, 1989Nov 6, 1990Bennett Jr William RDynamic spectral phonocardiograph
US4989611 *Aug 19, 1988Feb 5, 1991Seismed Instruments, Inc.Cardiac compression wave measuring system and method
US5002060 *Jun 14, 1989Mar 26, 1991Dror NediviMedical monitoring system
US5012815 *Jun 5, 1990May 7, 1991Yale UniversityDynamic spectral phonocardiograph
US5036859 *Sep 19, 1988Aug 6, 1991Travis International, Inc.Moisture detector and indicator
US5137033 *Jul 15, 1991Aug 11, 1992Norton John LPatient monitoring device
US5144284 *May 22, 1991Sep 1, 1992Hammett Rawlings HPatient-monitoring bed covering device
US5148002 *Mar 14, 1991Sep 15, 1992Kuo David DMulti-functional garment system
US5235989 *Sep 6, 1991Aug 17, 1993Sleep Disorders CenterApparatus for sensing respiration movements
US5241964 *Oct 31, 1990Sep 7, 1993Medwave, IncorporatedNoninvasive, non-occlusive method and apparatus which provides a continuous indication of arterial pressure and a beat-by-beat characterization of the arterial system
US5292340 *Jan 4, 1993Mar 8, 1994Telectronics Pacing Systems, Inc.Physiologically-calibrated rate adaptive, dual chamber pacemaker
US5309916 *Jul 16, 1991May 10, 1994Avl Medical Instruments AgBlood pressure measuring device and method
US5396893 *Feb 14, 1991Mar 14, 1995Oberg; Ake P.Method and apparatus for analyzing heart and respiratory frequencies photoplethysmographically
US5448996 *Feb 8, 1994Sep 12, 1995Lifesigns, Inc.Patient monitor sheets
US5479932 *Aug 16, 1993Jan 2, 1996Higgins; JosephInfant health monitoring system
US5490516 *May 6, 1993Feb 13, 1996Hutson; William H.Method and system to enhance medical signals for real-time analysis and high-resolution display
US5515865 *Apr 22, 1994May 14, 1996The United States Of America As Represented By The Secretary Of The ArmySudden Infant Death Syndrome (SIDS) monitor and stimulator
US5544651 *Feb 17, 1994Aug 13, 1996Wilk; Peter J.Medical system and associated method for automatic treatment
US5590649 *Apr 15, 1994Jan 7, 1997Vital Insite, Inc.Apparatus and method for measuring an induced perturbation to determine blood pressure
US5590650 *Nov 16, 1994Jan 7, 1997Raven, Inc.Non-invasive medical monitor system
US5620003 *Sep 15, 1993Apr 15, 1997Increa OyMethod and apparatus for measuring quantities relating to a persons cardiac activity
US5684460 *May 9, 1996Nov 4, 1997The United States Of America As Represented By The Secretary Of The ArmyMotion and sound monitor and stimulator
US5724025 *Feb 14, 1996Mar 3, 1998Tavori; ItzchakPortable vital signs monitor
US5724990 *Dec 29, 1995Mar 10, 1998Matsushita Electric Industrial Co., Ltd.Human monitoring apparatus
US5807267 *Aug 8, 1995Sep 15, 1998Advanced Body Metrics CorporationHeart pulse monitor
US5808552 *Nov 25, 1996Sep 15, 1998Hill-Rom, Inc.Patient detection system for a patient-support device
US5902255 *Nov 25, 1997May 11, 1999Matsushita Electric Industrial Co., Ltd.Human monitoring device
US5913826 *Jun 12, 1996Jun 22, 1999K-One TechnologiesWideband external pulse cardiac monitor
US5942979 *Apr 7, 1997Aug 24, 1999Luppino; RichardOn guard vehicle safety warning system
US5964720 *Nov 26, 1997Oct 12, 1999Adaptivity Devices Ltd.Method and system for monitoring the physiological condition of a patient
US5989193 *May 20, 1996Nov 23, 1999Somed Pty LimitedDevice and method for detecting and recording snoring
US6014346 *Feb 12, 1998Jan 11, 2000Accucure, L.L.C.Medical timer/monitor and method of monitoring patient status
US6047203 *Mar 17, 1998Apr 4, 2000Nims, Inc.Physiologic signs feedback system
US6050940 *Jun 17, 1997Apr 18, 2000Cybernet Systems CorporationGeneral-purpose medical instrumentation
US6068589 *Feb 14, 1997May 30, 2000Neukermans; Armand P.Biocompatible fully implantable hearing aid transducers
US6081742 *Sep 4, 1997Jun 27, 2000Seiko Epson CorporationOrganism state measuring device and relaxation instructing device
US6146332 *Jul 29, 1998Nov 14, 20003416704 Canada Inc.Movement detector
US6195008 *Sep 30, 1999Feb 27, 2001Biosys AbMethod and an apparatus for monitoring a seated person
US6198394 *Dec 5, 1996Mar 6, 2001Stephen C. JacobsenSystem for remote monitoring of personnel
US6248064 *Nov 10, 1998Jun 19, 2001Ineedmd.Com,Inc.Tele-diagnostic device
US6261237 *Aug 20, 1998Jul 17, 2001Medacoustics, Inc.Thin film piezoelectric polymer sensor
US6280392 *Jul 27, 1999Aug 28, 2001Denso CorporationInfant condition monitoring system and method using load cell sensor sheet
US6312387 *Jun 19, 1997Nov 6, 2001Polar Electro OyMethod and apparatus for identifying heartbeat
US6315719 *Jun 26, 2000Nov 13, 2001Astrium GmbhSystem for long-term remote medical monitoring
US6375621 *Dec 27, 1994Apr 23, 2002Ocean Laboratories, Inc.Passive apnea monitor
US6402691 *Sep 20, 2000Jun 11, 2002Herschel Q. PeddicordIn-home patient monitoring system
US6413223 *Jun 1, 2000Jul 2, 2002Massachussetts Institute Of TechnologyCuffless continuous blood pressure monitor
US6415033 *Mar 24, 2000Jul 2, 2002Ilife Systems, Inc.Physiological condition monitors utilizing very low frequency acoustic signals
US6425872 *Oct 18, 2000Jul 30, 2002Matsushita Electric Industrial Co., Ltd.System for measuring physical parameter utilizing vibration transmission
US6440082 *Sep 30, 1999Aug 27, 2002Medtronic Physio-Control Manufacturing Corp.Method and apparatus for using heart sounds to determine the presence of a pulse
US6450957 *Jul 7, 2000Sep 17, 2002Denso CorporationRespiratory disease monitoring system
US6475153 *May 10, 2000Nov 5, 2002Motorola Inc.Method for obtaining blood pressure data from optical sensor
US6485441 *Mar 28, 2001Nov 26, 2002The Board Of Trustees Of The Leland Stanford Junior UniversitySensorBed
US6506153 *Sep 1, 1999Jan 14, 2003Med-Dev LimitedMethod and apparatus for subject monitoring
US6540673 *Dec 19, 2000Apr 1, 2003Indeemd.Com, Inc.Tele-diagnostic device
US6547743 *May 18, 1998Apr 15, 2003Resmed LimitedRespiratory-analysis systems
US6554773 *Sep 14, 1998Apr 29, 2003Polar Electro OyMethod and arrangement for blood pressure measurement
US6565515 *Jan 22, 2002May 20, 2003Colin CorporationPulse-wave-propagation-velocity-relating-information obtaining apparatus and blood-pressure-index measuring apparatus
US6575902 *Dec 24, 1999Jun 10, 2003Compumedics LimitedVigilance monitoring system
US6575915 *Oct 4, 2001Jun 10, 2003Polar Electro OyMethod and apparatus for identifying heartbeat
US6575916 *Mar 24, 2000Jun 10, 2003Ilife Solutions, Inc.Apparatus and method for detecting very low frequency acoustic signals
US6579232 *Mar 23, 2001Jun 17, 2003Nihon Kohden CorporationVital sign monitor
US6599251 *Jul 27, 2001Jul 29, 2003Vsm Medtech Ltd.Continuous non-invasive blood pressure monitoring method and apparatus
US6600949 *May 5, 2000Jul 29, 2003Pacesetter, Inc.Method for monitoring heart failure via respiratory patterns
US6689069 *May 28, 2002Feb 10, 2004Hypertension Diagnostics, Inc.Apparatus and method for blood pressure pulse waveform contour analysis
US6984207 *Sep 14, 2000Jan 10, 2006Hoana Medical, Inc.Passive physiological monitoring (P2M) system
US6988989 *May 18, 2001Jan 24, 2006Welch Allyn Protocol, Inc.Patient monitoring system
US20020032383 *Jun 27, 2001Mar 14, 2002Weil Max HarryCardiac/respiratory arrest detector
USRE32180 *Nov 15, 1984Jun 10, 1986 Composite sheets constituting electromechanical transducers and transducers equipped with such sheets
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7304580Dec 3, 2004Dec 4, 2007Hoana Medical, Inc.Intelligent medical vigilance system
US7396331 *Oct 27, 2004Jul 8, 2008Home Guardian, LlcSystem and process for non-invasive collection and analysis of physiological signals
US7594891 *Dec 29, 2005Sep 29, 2009Moore Roy DPortable physiological parameter monitor
US7652581Feb 18, 2005Jan 26, 2010Hoana Medical, Inc.Method and system for integrating a passive sensor array with a mattress for patient monitoring
US7654962Jun 28, 2004Feb 2, 2010Hoana Medical, Inc.Radiation stress non-invasive blood pressure method
US7785257 *Jul 7, 2008Aug 31, 2010Home Guardian LlcSystem and process for non-invasive collection and analysis of physiological signals
US8372018 *Jan 16, 2008Feb 12, 2013International Business Machines CorporationSupport device and palpation device and methods of use
US8517953Jul 23, 2010Aug 27, 2013Earlysense Ltd.Techniques for prediction and monitoring of coughing-manifested clinical episodes
US8585607Nov 3, 2010Nov 19, 2013Earlysense Ltd.Monitoring, predicting and treating clinical episodes
US8641645Jan 11, 2013Feb 4, 2014International Business Machines CorporationUse of a support device
US8679030Jun 19, 2013Mar 25, 2014Earlysense Ltd.Monitoring a condition of a subject
US8731646Sep 6, 2013May 20, 2014Earlysense Ltd.Prediction and monitoring of clinical episodes
US8734360Oct 15, 2013May 27, 2014Earlysense Ltd.Monitoring, predicting and treating clinical episodes
US8821418May 10, 2009Sep 2, 2014Earlysense Ltd.Monitoring, predicting and treating clinical episodes
US8840564Jan 8, 2014Sep 23, 2014Early Sense Ltd.Monitoring a condition of a subject
US8855761Jul 10, 2009Oct 7, 2014Texas Heart InstituteMethod and system for temperature analysis to provide an early marker of congestive heart failure progress that precedes a patient's symptoms
US8870791Mar 26, 2012Oct 28, 2014Michael E. SabatinoApparatus for acquiring, processing and transmitting physiological sounds
US8882684May 30, 2013Nov 11, 2014Earlysense Ltd.Monitoring, predicting and treating clinical episodes
US8920343Nov 20, 2006Dec 30, 2014Michael Edward SabatinoApparatus for acquiring and processing of physiological auditory signals
US8942779Aug 7, 2014Jan 27, 2015Early Sense Ltd.Monitoring a condition of a subject
US8992434Apr 1, 2014Mar 31, 2015Earlysense Ltd.Prediction and monitoring of clinical episodes
US8998830Aug 13, 2014Apr 7, 2015Earlysense Ltd.Monitoring, predicting and treating clinical episodes
US9026199Dec 2, 2014May 5, 2015Earlysense Ltd.Monitoring a condition of a subject
US9131902Feb 18, 2015Sep 15, 2015Earlysense Ltd.Prediction and monitoring of clinical episodes
US9332930Jan 16, 2014May 10, 2016International Business Machines CorporationUse of a support device
US9532733Mar 23, 2016Jan 3, 2017International Business Machines CorporationUse of a support device
US20050124864 *Oct 27, 2004Jun 9, 2005Mack David C.System and process for non-invasive collection and analysis of physiological signals
US20050190062 *Dec 3, 2004Sep 1, 2005Sullivan Patrick K.Intelligent medical vigilance system
US20050190068 *Feb 18, 2005Sep 1, 2005Gentry Jason M.Method and system for integrating a passive sensor array with a mattress for patient monitoring
US20070156052 *Dec 29, 2005Jul 5, 2007Moore Roy DPortable physiological parameter monitor
US20070265535 *Jun 28, 2004Nov 15, 2007Sullivan Patrick KRadiation Stress Non-Invasive Blood Pressure Method
US20070282174 *Nov 20, 2006Dec 6, 2007Sabatino Michael ESystem and method for acquisition and analysis of physiological auditory signals
US20080200800 *Feb 15, 2008Aug 21, 2008Shigehide KuharaRespiration suppressing mat and magnetic resonance imaging apparatus and method
US20080242947 *Mar 30, 2007Oct 2, 2008Searete Llc, A Limited Liability Corporation Of The State Of DelawareConfiguring software for effective health monitoring or the like
US20080242948 *Mar 30, 2007Oct 2, 2008Searete Llc, A Limited Liability Corporation Of The State Of DelawareEffective low-profile health monitoring or the like
US20080242949 *May 15, 2007Oct 2, 2008Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational user-health testing
US20080242951 *May 29, 2007Oct 2, 2008Searete Llc, A Limited Liability Corporation Of The State Of DelawareEffective low-profile health monitoring or the like
US20080242952 *May 29, 2007Oct 2, 2008Searete Llc, A Limited Liablity Corporation Of The State Of DelawareEffective response protocols for health monitoring or the like
US20080243005 *Jun 11, 2007Oct 2, 2008Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational user-health testing
US20080243543 *Mar 30, 2007Oct 2, 2008Searete Llc, A Limited Liability Corporation Of The State Of DelawareEffective response protocols for health monitoring or the like
US20080275314 *Jul 7, 2008Nov 6, 2008Home Guardian LlcSystem and Process for Non-Invasive Collection and Analysis of Physiological Signals
US20080319276 *Jun 2, 2008Dec 25, 2008Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational user-health testing
US20090005653 *Jun 2, 2008Jan 1, 2009Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational user-health testing
US20090005654 *Jun 3, 2008Jan 1, 2009Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational user-health testing
US20090018407 *May 20, 2008Jan 15, 2009Searete Llc, A Limited Corporation Of The State Of DelawareComputational user-health testing
US20090024050 *May 29, 2008Jan 22, 2009Searete Llc, A Limited Liability Corporation Of The State Of DelawareComputational user-health testing
US20090118593 *Jun 10, 2008May 7, 2009Searete Llc, A Limited Liability Corporation Of The State Of DelawareDetermining a demographic characteristic based on computational user-health testing of a user interaction with advertiser-specified content
US20090119154 *Nov 7, 2007May 7, 2009Searete Llc, A Limited Liability Corporation Of The State Of DelawareDetermining a demographic characteristic based on computational user-health testing of a user interaction with advertiser-specified content
US20090182247 *Jan 16, 2008Jul 16, 2009International Business Machines CorporationSupport device and palpation device and methods of use
US20100010552 *Jul 10, 2009Jan 14, 2010Texas Heart InstituteMethod and system for temperature analysis to provide an early marker of congestive heart failure progress that precedes a patient's symptoms
US20100058480 *Jul 13, 2006Mar 4, 2010Sven-Erik HedbergInformation management in devices worn by a user
US20100256505 *Apr 3, 2009Oct 7, 2010Jingping XuHealth monitoring method and system
US20110087113 *Aug 30, 2010Apr 14, 2011Wellaware Systems, Inc.System and Process For Non-Invasive Collection and Analysis of Physiological Signals
WO2010006265A2 *Jul 10, 2009Jan 14, 2010Texas Heart InstituteMethod and system for temperature analysis to provide an early marker of congestive heart failure progress that precedes a patient's symptoms
WO2010006265A3 *Jul 10, 2009May 6, 2010Texas Heart InstituteMethod and system for temperature analysis to provide an early marker of congestive heart failure progress that precedes a patient's symptoms
Classifications
U.S. Classification600/301, 600/481
International ClassificationA61B5/02, A61B5/00
Cooperative ClassificationA61B5/02125, A61B5/7203, A61B5/0205, A61B5/7257, A61B5/021, A61B5/024, A61B5/11, A61B2562/043, A61B5/113, A61B2562/0247, A61B5/0002, A61B5/08
European ClassificationA61B5/72B, A61B5/021, A61B5/113, A61B5/00B